{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T02:52:37Z","timestamp":1770346357629,"version":"3.49.0"},"reference-count":32,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,6,4]],"date-time":"2004-06-04T00:00:00Z","timestamp":1086307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The ratio of osteoprotegerin [OPG, tumour necrosis factor receptor superfamily, member 11b (TNFRSF11B)] to receptor activator of nuclear factor \u03baB ligand [RANKL, tumour necrosis factor (ligand) superfamily, member 11 (TNFSF11)] in bone is critical for the regulation of bone remodelling. Myeloma cells can home to bone, triggering increased RANKL and decreased OPG expression by stromal cells, leading to osteolysis. Whether myeloma cells contribute directly to the pool of RANKL or OPG in bone has been contentious. Here we provide evidence of RANKL expression by reverse transcription polymerase chain reaction and <jats:italic>in situ<\/jats:italic> hybridization, demonstrating transcripts encoding both the membrane\u2010bound and secreted forms of RANKL in five human multiple myeloma cell lines (LP\u20101, NCI\u2010H929, OPM\u20102, RPMI8226, U266) and myeloma cells purified from bone marrow aspirates of myeloma patients. We demonstrated that RANKL encoding mRNAs are translated to protein by antibody detection of RANKL. <jats:italic>In vitro<\/jats:italic> assays showed that myeloma cells induced bone marrow derived mononuclear cells to differentiate into adherent tartrate\u2010resistant acid phosphatase positive multinucleated cells, indicative of the formation of functional osteoclasts. This differentiation could also be achieved with passaged myeloma media alone, implicating secreted products. Finally, we provide evidence that the differentiation observed is at least in part the result of myeloma cell expression of RANKL. We therefore conclude that myeloma cells can directly contribute to the pool of RANKL in bone.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.05018.x","type":"journal-article","created":{"date-parts":[[2004,7,2]],"date-time":"2004-07-02T06:05:49Z","timestamp":1088748349000},"page":"192-201","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation"],"prefix":"10.1111","volume":"126","author":[{"given":"F. P. L.","family":"Lai","sequence":"first","affiliation":[]},{"given":"M.","family":"Cole\u2010Sinclair","sequence":"additional","affiliation":[]},{"given":"W.\u2010J.","family":"Cheng","sequence":"additional","affiliation":[]},{"given":"J. M. W.","family":"Quinn","sequence":"additional","affiliation":[]},{"given":"M. T.","family":"Gillespie","sequence":"additional","affiliation":[]},{"given":"J. W.","family":"Sentry","sequence":"additional","affiliation":[]},{"given":"H.\u2010G.","family":"Schneider","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2004,6,4]]},"reference":[{"key":"e_1_2_17_2_1","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V100.6.2195","article-title":"Role for macrophage inflammatory protein (MIP)\u20101alpha and MIP\u20101beta in the development of osteolytic lesions in multiple myeloma","author":"Abe M.","year":"2002","journal-title":"Blood"},{"key":"e_1_2_17_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2003.1.248"},{"key":"e_1_2_17_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90020-4"},{"key":"e_1_2_17_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X"},{"key":"e_1_2_17_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3534"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2001.1.157"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)02440-3"},{"key":"e_1_2_17_9_1","first-page":"5438","article-title":"Receptor activator of nuclear factor\u2010kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo","volume":"63","author":"Farrugia A.N.","year":"2003","journal-title":"Cancer Research"},{"key":"e_1_2_17_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00103-3"},{"key":"e_1_2_17_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3527"},{"key":"e_1_2_17_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3349"},{"key":"e_1_2_17_13_1","first-page":"1436","article-title":"Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma","volume":"9","author":"Heider U.","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_17_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(99)00214-8"},{"key":"e_1_2_17_15_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.2.275"},{"key":"e_1_2_17_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/16852"},{"key":"e_1_2_17_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(00)01718-7"},{"key":"e_1_2_17_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81569-X"},{"key":"e_1_2_17_19_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.5.2625"},{"key":"e_1_2_17_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.201394498"},{"key":"e_1_2_17_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M302518200"},{"key":"e_1_2_17_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.139.10.6331"},{"key":"e_1_2_17_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03417.x"},{"key":"e_1_2_17_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.7.2269"},{"key":"e_1_2_17_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.1.353"},{"key":"e_1_2_17_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80209-3"},{"key":"e_1_2_17_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1190"},{"key":"e_1_2_17_28_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.20.3.0367"},{"key":"e_1_2_17_29_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0252"},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04561.x"},{"key":"e_1_2_17_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)00019-2"},{"key":"e_1_2_17_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04040.x"},{"key":"e_1_2_17_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770100296"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05018.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05018.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.05018.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:47:56Z","timestamp":1697424476000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.05018.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1111\/j.1365-2141.2004.05018.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05018.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,4]]},"assertion":[{"value":"2004-06-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}